# 2026-12140: Research Lab Applies to Import Ibogaine and Marijuana

2026-12140, Importer of Controlled Substances Application: Scottsdale Research Institute, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-06-17, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before July 17, 2026. Such persons may also file a written request for a hearing on the application on or before July 17, 2026.; PRIA reads it as touching household money (as of 2026-06-24).

- Canonical: https://policyrisk.com/federal-register/2026-12140
- As of: 2026-06-24
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-12140
- Title: Importer of Controlled Substances Application: Scottsdale Research Institute
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 36617
- Published: 2026-06-17
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before July 17, 2026. Such persons may also file a written request for a hearing on the application on or before July 17, 2026.
- Comments close: 2026-07-17
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-24

## In one line

Research Lab Applies to Import Ibogaine and Marijuana

## Summary

Scottsdale Research Institute wants to become an official importer of some controlled substances like ibogaine and marijuana. People who make or import these drugs can share their thoughts or ask for a hearing by July 17, 2026. This move could affect how these substances are brought into the U.S., but no costs or fees are mentioned yet.

## Abstract

Scottsdale Research Institute has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

## Effects PRIA read

- Importer application could supply researchers: benefit, medium. Scottsdale Research Institute applied on May 19, 2026 to register as an importer of Schedule I bulk active pharmaceutical ingredients for ibogaine (drug code 7260), marihuana (7360), and 3,4‑Methylenedioxymethamphetamine/MDMA (7405). The company says it plans to import these bulk APIs to support cl…
- Synthetic cannabidiol imported under marijuana code: benefit, low. For the marihuana drug code (7360), Scottsdale Research Institute plans specifically to import a synthetic cannabidiol as a bulk active pharmaceutical ingredient. That import would be intended to support clinical research by Schedule I registrants.
- Registration excludes finished drug imports for sale: cost, low. The notice states that approval of this importer registration will not authorize importation of Food and Drug Administration‑approved or non‑approved finished dosage forms for commercial sale. The registrant’s authorization is limited to the activities allowed under 21 U.S.C. 952(a)(2).

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-20749](https://policyrisk.com/federal-register/2026-20749): Vladimir Romaniv, P.A.; Decision and Order, 2026-10-09
- [2026-20750](https://policyrisk.com/federal-register/2026-20750): L Krenk DBA Maui Clinic Pharmacy; Decision and Order, 2026-10-09

## Sources
- [2026-12140 on federalregister.gov](https://www.federalregister.gov/documents/2026/06/17/2026-12140/importer-of-controlled-substances-application-scottsdale-research-institute)
- [2026-12140 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-06-17/pdf/2026-12140.pdf)

## Related
- [Previous: 2026-12138, Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pha…](https://policyrisk.com/federal-register/2026-12138)
- [Next: 2026-12141, Importer of Controlled Substances Application: Veranova, L.P.](https://policyrisk.com/federal-register/2026-12141)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-12140 (as of 2026-06-24).